| (19) |
 |
|
(11) |
EP 0 887 415 A3 |
| (12) |
EUROPEAN PATENT APPLICATION |
| (88) |
Date of publication A3: |
|
07.01.1999 Bulletin 1999/01 |
| (43) |
Date of publication A2: |
|
30.12.1998 Bulletin 1998/53 |
| (22) |
Date of filing: 18.06.1998 |
|
|
| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
| (30) |
Priority: |
24.06.1997 EP 97304437
12.02.1998 US 22669
|
| (71) |
Applicants: |
|
- SMITHKLINE BEECHAM CORPORATION
Philadelphia
Pennsylvania 19103 (US)
- SMITHKLINE BEECHAM PLC
Brentford,
Middlesex TW8 9EP (GB)
|
|
| (72) |
Inventors: |
|
- Kikly, Kristine,
SmithKline Beecham Pharm.
King of Prussia,
Pennsylvania 19406 (US)
- Knab, Anna,
SmithKline Beecham Pharm.
King of Prussia,
Pennsylvania 19406 (US)
- Southan, Christopher,
SmithKline Beecham PLC
Brentford Middlesex TW8 9EP (GB)
|
| (74) |
Representative: Connell, Anthony Christopher et al |
|
SmithKline Beecham plc
Corporate Intellectual Property,
Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB) |
|
| |
|
(57) The hRCE1 polypeptides and polynucleotides and methods for producing such polypeptides
by recombinant techniques are disclosed. Also disclosed are methods for utilizing
hRCE1 polypeptides and polynucleotides in therapy, and diagnostic assays for such.